Healios: Robbie Allen

Robbie Allen

Healios, a London-based digital provider of mental health, autism and ADHD services for children and young people, has appointed Robbie Allen as its new chair, replacing Dr Graham Rich, who held the position for three-and-a-half years.

Allen has more than 30 years’ experience leading healthcare organisations ranging from start-ups to billion-dollar enterprises. Allen, who is based in Nashville, Tennessee, sits on several boards of US firms as well as being the chief executive of gastroenterology management services organisation One GI.

Rich Andrews, Healios founder and chief executive, said: “Robbie is a seasoned CEO, entrepreneur and board member, having founded, scaled and led healthcare companies for over 30 years, including founding the first US telemedicine company. Robbie’s extensive experience will be invaluable as we navigate this next chapter of growth to reach many more young lives. He is passionate about empowering clinical teams to deliver great care, as well as embracing the intersection of clinicians and technology to solve major challenges in service provision. It is a testament to our purpose, vision, reputation, innovation and the quality of our services that we continue to attract phenomenal talent to the company at all levels.”

Allen said: “Healios is already a market leader in many aspects of adolescent mental health and autism diagnosis and support, and I am thrilled at the prospect of joining its board to help enable their continued success and growth in the global markets it serves. Adopting a digital-first clinical approach, Healios has redefined the way mental health, autism and ADHD services are delivered to children, young people and families in the UK and beyond since it was founded in 2013.

Last November, Healios completed a £14 million funding round with participation from existing investors AlbionVC and InHealth Ventures.

Join our mailing list

Stay up to date with all our events, awards and publications.

Information you provide us with will be kept private at all times, and will be used for communication and research purpose only.